A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis

Aún no traducido Aún no traducido
Autores
Categoría Estudio primario
Registro de estudiosClinicalTrials.gov
Año 2006
This is a phase III, randomized, controlled, double-blind, parallel group, international study in approximately 750 patients with active Rheumatoid Arthritis (RA) who are naive to Methotrexate (MTX) therapy. Rheumatoid Factor (RF)-positive and RF-negative patients will be enrolled and will be allocated equally between 3 treatment arms.
Epistemonikos ID: 2c293e85cc658443906042f6987ef52a3ef2ccf7
First added on: Mar 23, 2022